×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Calithera Biosciences Inc. (CALA) OTC MARKETS

$0.02 - (-)

Market Cap: $97450

As of 05/23/24 04:00 PM EDT. Market closed.

(CALA)

Calithera Biosciences Inc. (CALA)
OTC MARKETS

$0.02
- (-)

Market Cap: $97450

As of 05/23/24 04:00 PM EDT. Market closed.

Add to Portfolio

calithera is focused on discovering and developing first-in-class small molecule drugs that slow tumor growth through controlling key metabolic pathways in the tumor and immune cells. tumor metabolism and tumor immunology are promising new interrelated fields for cancer drug discovery. recent clinical successes have demonstrated the potential to slow abnormal cell growth and create fundamentally ... read more

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Susan Molineaux
Full Time Employees
58
CEO Compensation (Base)
$530,000
CEO Compensation (Total)
$2.03M
URL
Address
343 Oyster Point Blvd # 200, California, South San Francisco, 94080-1913.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Susan Molineaux
Full Time Employees
58
CEO Compensation (Base)
$530,000
CEO Compensation (Total)
$2.03M
Address
343 Oyster Point Blvd # 200, California, South San Francisco, 94080-1913.
PRICE CHART FOR CALITHERA BIOSCIENCES INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.40
Previous Close
$0.02
Days Range
$0.02 - $0.02
52 week range
$0.02 - $0.50
Volume
15
Avg. Volume (30 days)
6,177
Market Cap
$97450
Dividend Yield
-
P/E
-
Shares Outstanding
4,872,497
Open
$0.40
Previous Close
$0.02
Days Range
$0.02 - $0.02
52 week range
$0.02 - $0.50
Volume
15
Avg. Volume (30 days)
6,177
Market Cap
$97450
Dividend Yield
-
P/E
-
Shares Outstanding
4,872,497
FINANCIAL STATEMENTS FOR CALITHERA BIOSCIENCES INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR CALITHERA BIOSCIENCES INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
PAKIANATHAN DEEPIKADirectorJan 27, 2023 Sale$0.391,1724520Jan 31, 2023, 07:04 PM
PAKIANATHAN DEEPIKADirectorJan 27, 2023 Sale$0.39120,16146,3580Jan 31, 2023, 07:04 PM
Sjogren EricSR. VP, DRUG DISCOVERYJan 23, 2023 Option Exercise$0.452791248,467Jan 25, 2023, 04:00 PM
Kuriakose EmilCHIEF MEDICAL OFFICERJan 23, 2023 Option Exercise$0.4579353,539Jan 25, 2023, 04:00 PM
Molineaux SusanPRESIDENT & CEOJan 23, 2023 Option Exercise$0.4552623527,859Jan 25, 2023, 04:00 PM
Wong StephanieSee RemarksJan 23, 2023 Option Exercise$0.453171416,287Jan 25, 2023, 04:00 PM
Molineaux ChristopherSR. VP, DEVELOPMENTJan 23, 2023 Option Exercise$0.452179727,859Jan 25, 2023, 04:00 PM
Parlati FrancescoSR. VP, RESEARCHJan 21, 2022 Option Exercise$0.494,7942,356140,998Jan 25, 2022, 04:05 PM
Wong StephanieSee RemarksJan 21, 2022 Option Exercise$0.495,5862,746132,085Jan 25, 2022, 04:05 PM
Sjogren EricSR. VP, DRUG DISCOVERYJan 21, 2022 Option Exercise$0.494,7942,356172,434Jan 25, 2022, 04:05 PM
Parlati FrancescoSR. VP, RESEARCHJan 04, 2022 Option Exercise$0.6618,07711,938145,792Jan 06, 2022, 09:00 PM
Kuriakose EmilCHIEF MEDICAL OFFICERJan 04, 2022 Option Exercise$0.663,8552,54668,035Jan 06, 2022, 09:00 PM
Sjogren EricSR. VP, DRUG DISCOVERYJan 04, 2022 Option Exercise$0.6618,07711,938177,228Jan 06, 2022, 09:00 PM
Wong StephanieSee RemarksJan 04, 2022 Option Exercise$0.6618,07711,938137,671Jan 06, 2022, 09:00 PM
Orford KeithDirectorNov 11, 2021 Sale$0.8848,19042,40766,094Nov 12, 2021, 05:30 PM
Orford KeithDirectorNov 10, 2021 Sale$0.8630,00025,695114,284Nov 12, 2021, 05:30 PM
Molineaux SusanPRESIDENT & CEONov 10, 2021 Buy$0.85100,00084,670557,188Nov 10, 2021, 07:34 PM
DRACHMAN JONATHAN GDirectorNov 10, 2021 Buy$0.86200,000171,900200,000Nov 10, 2021, 07:31 PM
Molineaux ChristopherSR. VP, DEVELOPMENTNov 10, 2021 Buy$0.85100,00084,670557,188Nov 10, 2021, 07:28 PM
Orford KeithDirectorNov 09, 2021 Sale$0.8451,81043,520144,284Nov 09, 2021, 07:39 PM
Sjogren EricSR. VP, DRUG DISCOVERYNov 08, 2021 Option Exercise$0.8715,56613,542195,305Nov 09, 2021, 07:35 PM
Wong StephanieSee RemarksNov 08, 2021 Option Exercise$0.8715,56613,542155,748Nov 09, 2021, 07:34 PM
Kuriakose EmilCHIEF MEDICAL OFFICERNov 08, 2021 Option Exercise$0.873,0772,67769,390Nov 09, 2021, 07:32 PM
Parlati FrancescoSR. VP, RESEARCHNov 08, 2021 Option Exercise$0.8715,56613,542163,869Nov 09, 2021, 07:28 PM
Sjogren EricSR. VP, DRUG DISCOVERYOct 28, 2021 Option Exercise$1.8945,96586,874180,871Oct 29, 2021, 06:55 PM
Wong StephanieSee RemarksOct 28, 2021 Option Exercise$1.8945,96586,874141,314Oct 29, 2021, 06:50 PM
Parlati FrancescoSR. VP, RESEARCHOct 28, 2021 Option Exercise$1.8945,96586,874149,435Oct 29, 2021, 06:47 PM
Orford KeithChief Medical OfficerDec 16, 2020 Sale$6.002,44714,68211,094Dec 18, 2020, 05:00 PM
BVF PARTNERS L P/IL10% OwnerMay 21, 2020 Sale$6.002,283,59813,701,5883,712,340May 26, 2020, 05:52 PM
Wong StephanieSR. VP, FINANCE & SECRETARYApr 15, 2020 Sale$8.005,00040,00030,082Apr 17, 2020, 04:05 PM
Orford KeithChief Medical OfficerFeb 20, 2020 Sale$8.003,02124,1688,541Feb 24, 2020, 04:05 PM
Orford KeithChief Medical OfficerDec 23, 2019 Sale$6.003,02118,12611,562Dec 26, 2019, 04:01 PM
BVF PARTNERS L P/IL10% OwnerNov 20, 2019 Buy$3.91191,954750,8474,739,356Nov 22, 2019, 07:53 PM
BVF PARTNERS L P/IL10% OwnerNov 14, 2019 Buy$3.37128,488433,0054,640,838Nov 18, 2019, 06:38 PM
BVF PARTNERS L P/IL10% OwnerOct 30, 2019 Buy$2.70797,5082,153,2724,569,343Oct 31, 2019, 06:27 PM
BVF PARTNERS L P/IL10% OwnerOct 29, 2019 Buy$2.601,598,9774,157,3404,160,751Oct 31, 2019, 06:27 PM
Molineaux ChristopherSR. VP, DEVELOPMENTJun 25, 2019 Buy$3.8851,600200,208457,188Jun 27, 2019, 04:06 PM
Molineaux SusanPRESIDENT AND CEOJun 25, 2019 Buy$3.8851,600200,208457,188Jun 27, 2019, 04:05 PM
Sjogren EricSR. VP, DRUG DISCOVERYJun 24, 2019 Option Exercise$0.9621,73920,86972,057Jun 26, 2019, 04:05 PM
Wong StephanieSR. VP, FINANCE & SECRETARYJun 19, 2019 Option Exercise$2.6410,00026,40031,751Jun 21, 2019, 04:05 PM
Parlati FrancescoVP, RESEARCHJun 17, 2019 Option Exercise$2.646,24616,48942,201Jun 19, 2019, 04:06 PM
Orford KeithChief Medical OfficerJun 17, 2019 Sale$6.004172,50212,083Jun 19, 2019, 04:05 PM
Orford KeithChief Medical OfficerMay 22, 2019 Sale$6.004162,49610,000May 24, 2019, 04:05 PM
Orford KeithChief Medical OfficerApr 15, 2019 Sale$6.334162,63310,416Apr 17, 2019, 04:05 PM
Orford KeithChief Medical OfficerMar 15, 2019 Sale$6.434172,68110,832Mar 19, 2019, 04:05 PM
Orford KeithChief Medical OfficerMar 11, 2019 Sale$6.001,5659,39011,249Mar 13, 2019, 04:10 PM
Orford KeithSR. VP, CLINICAL DEVELOPMENTOct 15, 2018 Sale$6.053131,89410,314Oct 17, 2018, 05:00 PM
Orford KeithSR. VP, CLINICAL DEVELOPMENTOct 11, 2018 Sale$6.001,2527,51210,627Oct 15, 2018, 05:00 PM
Sjogren EricSR. VP, DRUG DISCOVERYApr 03, 2018 Option Exercise$0.4816,8108,06942,818Apr 05, 2018, 04:06 PM
Molineaux SusanPRESIDENT AND CEOMar 02, 2018 Option Exercise$2.6426,99271,25944,860Mar 06, 2018, 04:12 PM
Parlati FrancescoVP, RESEARCHFeb 20, 2018 Option Exercise$0.965,0954,89128,455Mar 06, 2018, 04:11 PM
Molineaux ChristopherSR. VP, DEVELOPMENTMar 02, 2018 Option Exercise$2.646,79817,94721,000Mar 06, 2018, 04:08 PM
Wong StephanieSR VP, FINANCE AND SECRETARYFeb 23, 2018 Option Exercise$2.6410,00026,40015,000Feb 27, 2018, 07:26 PM
Parlati FrancescoVP, RESEARCHFeb 20, 2018 Option Exercise$0.965,0954,89120,488Feb 22, 2018, 04:05 PM
Molineaux SusanPRESIDENT AND CEODec 05, 2017 Option Exercise$1.6512,86821,25715,368Dec 06, 2017, 04:05 PM
Molineaux ChristopherSR. VP, DEVELOPMENTDec 05, 2017 Option Exercise$1.459,20213,37011,702Dec 06, 2017, 04:05 PM
ADAGE CAPITAL PARTNERS GP, L.L.C.10% OwnerSep 28, 2017 Sale$15.5038,000589,0003,546,873Sep 28, 2017, 04:10 PM
ADAGE CAPITAL PARTNERS GP, L.L.C.10% OwnerSep 27, 2017 Sale$15.59186,0002,899,7403,584,873Sep 28, 2017, 04:10 PM
ADAGE CAPITAL PARTNERS GP, L.L.C.10% OwnerSep 26, 2017 Sale$15.68352,0005,519,3603,770,873Sep 28, 2017, 04:10 PM
Wong StephanieVP, FINANCE AND SECRETARYJul 17, 2017 Sale$18.413,55265,38510,550Jul 19, 2017, 04:06 PM
Orford KeithSR. VP, CLINICAL DEVELOPMENTJul 17, 2017 Sale$18.312,12038,8236,879Jul 19, 2017, 04:05 PM
Hecht CurtisSVP, BUS. & CORP. DEVELOPMENTJul 06, 2017 Sale$18.0070012,60015,940Jul 07, 2017, 04:07 PM
Hecht CurtisSVP, BUS. & CORP. DEVELOPMENTMay 19, 2017 Sale$16.0065010,40014,910May 23, 2017, 04:05 PM
ADAGE CAPITAL PARTNERS GP, L.L.C.10% OwnerMar 22, 2017 Buy$10.25487,8044,999,9914,122,873Mar 24, 2017, 10:00 AM
Hecht CurtisSVP, BUS. & CORP. DEVELOPMENTMar 13, 2017 Sale$14.006008,40015,560Mar 15, 2017, 04:05 PM
Hecht CurtisSee RemarksMar 02, 2017 Sale$12.005506,60016,160Mar 06, 2017, 04:05 PM
Molineaux SusanPRESIDENT AND CEODec 19, 2016 Option Exercise$2.1621,93347,30923,810Dec 20, 2016, 09:00 AM
Molineaux ChristopherSR. VP, DEVELOPMENTDec 19, 2016 Option Exercise$1.7410,16717,73912,044Dec 20, 2016, 09:00 AM
ADAGE CAPITAL PARTNERS GP, L.L.C.10% OwnerNov 16, 2016 Buy$3.15500,0001,575,0003,635,069Nov 17, 2016, 05:07 PM
Molineaux SusanPRESIDENT AND CEOJul 20, 2016 Option Exercise$1.8129,38553,21831,885Jul 21, 2016, 07:30 AM
Molineaux ChristopherSR. VP, DEVELOPMENTJul 20, 2016 Option Exercise$1.6112,33519,82014,835Jul 21, 2016, 07:30 AM
Bennett Mark KSR. VP, RESEARCHDec 29, 2015 Option Exercise$1.6010,41316,61710,413Dec 31, 2015, 03:24 PM
Molineaux SusanPRESIDENT AND CEODec 21, 2015 Option Exercise$1.4927,82541,525109,112Dec 23, 2015, 07:13 PM
Molineaux ChristopherSR. VP, DEVELOPMENTDec 21, 2015 Option Exercise$1.7410,16717,73939,542Dec 23, 2015, 07:10 PM
Hecht CurtisVP, BUS. & CORP. DEVELOPMENTNov 16, 2015 Sale$6.589706,3858,625Nov 18, 2015, 07:51 PM
ADAGE CAPITAL PARTNERS GP LLC10% OwnerSep 23, 2015 Buy$6.0740,168243,7683,135,069Sep 24, 2015, 04:43 PM
ADAGE CAPITAL PARTNERS GP LLC10% OwnerSep 22, 2015 Buy$6.0066,800400,8803,094,901Sep 24, 2015, 04:43 PM
ADAGE CAPITAL PARTNERS GP LLC10% OwnerSep 04, 2015 Buy$5.952,30013,6853,028,101Sep 08, 2015, 05:05 PM
ADAGE CAPITAL PARTNERS GP LLC10% OwnerSep 03, 2015 Buy$5.9388,000521,8403,025,801Sep 08, 2015, 05:05 PM
ADAGE CAPITAL PARTNERS GP LLC10% OwnerAug 26, 2015 Buy$4.6532,258150,0102,797,933Aug 28, 2015, 05:46 PM
ADAGE CAPITAL PARTNERS GP LLC10% OwnerAug 28, 2015 Buy$5.5742,700237,6452,937,801Aug 28, 2015, 05:46 PM
ADAGE CAPITAL PARTNERS GP LLC10% OwnerAug 27, 2015 Buy$5.3597,168520,2072,895,101Aug 28, 2015, 05:46 PM
Hecht CurtisVP, BUS. & CORP. DEVELOPMENTAug 20, 2015 Option Exercise$2.642,0005,2808,625Aug 24, 2015, 05:18 PM
Waddill William D.SR. VP & CFOJul 14, 2015 Option Exercise$2.6413,12534,65015,625Jul 16, 2015, 05:41 PM
Molineaux SusanPRESIDENT AND CEOJul 13, 2015 Option Exercise$1.4476,287109,89078,787Jul 15, 2015, 07:52 PM
Molineaux ChristopherSR. VP, DEVELOPMENTJul 13, 2015 Option Exercise$1.6724,37540,68426,875Jul 15, 2015, 07:49 PM
Bennett Mark KSR. VP, RESEARCHJul 08, 2015 Option Exercise$1.5318,36528,17419,501Jul 10, 2015, 07:08 PM
Waddill William D.SENIOR VP & CFODec 16, 2014 Option Exercise$3.436,79723,28416,172Dec 18, 2014, 05:19 PM
ADAGE CAPITAL PARTNERS GP LLC10% OwnerOct 15, 2014 Buy$6.9538,000264,2502,765,675Oct 15, 2014, 07:51 PM
ADAGE CAPITAL PARTNERS GP LLC10% OwnerOct 14, 2014 Buy$7.0055,000384,7502,727,375Oct 15, 2014, 07:51 PM
ADAGE CAPITAL PARTNERS GP LLC10% OwnerOct 13, 2014 Buy$6.9488,700615,5782,672,375Oct 15, 2014, 07:51 PM
Delphi Management Partners VIII, L.L.C.10% OwnerOct 07, 2014 Buy$10.004,83548,35023,464Oct 09, 2014, 08:44 PM
Delphi Management Partners VIII, L.L.C.10% OwnerOct 07, 2014 Buy$10.00495,1654,951,6502,403,238Oct 09, 2014, 08:44 PM
PAKIANATHAN DEEPIKADirectorOct 07, 2014 Buy$10.004,83548,35023,464Oct 09, 2014, 04:49 PM
PAKIANATHAN DEEPIKADirectorOct 07, 2014 Buy$10.00495,1654,951,6502,403,238Oct 09, 2014, 04:49 PM
Advanced Technology Ventures VIII LP10% OwnerOct 07, 2014 Buy$10.00300,0003,000,0002,110,082Oct 09, 2014, 04:45 PM
MORGENTHALER VENTURE PARTNERS IX LP10% OwnerOct 07, 2014 Option Exercise$10.001,811,91518,119,1501,811,915Oct 09, 2014, 04:43 PM
MORGENTHALER VENTURE PARTNERS IX LP10% OwnerOct 07, 2014 Buy$10.00350,0003,500,0002,161,915Oct 09, 2014, 04:43 PM
Christoffersen Ralph EDirectorOct 07, 2014 Buy$10.00350,0003,500,0002,161,915Oct 09, 2014, 04:41 PM
George JeanDirectorOct 07, 2014 Buy$10.00300,0003,000,0002,110,082Oct 09, 2014, 04:40 PM
ADAGE CAPITAL PARTNERS GP LLC10% OwnerOct 01, 2014 Buy$10.00800,0008,000,0002,583,675Oct 03, 2014, 12:25 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
PAKIANATHAN DEEPIKADirector01/27/2023452
PAKIANATHAN DEEPIKADirector01/27/202346,358
Sjogren EricSR. VP, DRUG DISCOVERY01/23/2023124
Kuriakose EmilCHIEF MEDICAL OFFICER01/23/202335
Molineaux SusanPRESIDENT & CEO01/23/2023235
Wong StephanieSee Remarks01/23/2023141
Molineaux ChristopherSR. VP, DEVELOPMENT01/23/202397
Parlati FrancescoSR. VP, RESEARCH01/21/20222,356
Wong StephanieSee Remarks01/21/20222,746
Sjogren EricSR. VP, DRUG DISCOVERY01/21/20222,356
Parlati FrancescoSR. VP, RESEARCH01/04/202211,938
Kuriakose EmilCHIEF MEDICAL OFFICER01/04/20222,546
Sjogren EricSR. VP, DRUG DISCOVERY01/04/202211,938
Wong StephanieSee Remarks01/04/202211,938
Orford KeithDirector11/11/202142,407
Orford KeithDirector11/10/202125,695
Molineaux SusanPRESIDENT & CEO11/10/202184,670
DRACHMAN JONATHAN GDirector11/10/2021171,900
Molineaux ChristopherSR. VP, DEVELOPMENT11/10/202184,670
Orford KeithDirector11/09/202143,520
Sjogren EricSR. VP, DRUG DISCOVERY11/08/202113,542
Wong StephanieSee Remarks11/08/202113,542
Kuriakose EmilCHIEF MEDICAL OFFICER11/08/20212,677
Parlati FrancescoSR. VP, RESEARCH11/08/202113,542
Sjogren EricSR. VP, DRUG DISCOVERY10/28/202186,874
Wong StephanieSee Remarks10/28/202186,874
Parlati FrancescoSR. VP, RESEARCH10/28/202186,874
Orford KeithChief Medical Officer12/16/202014,682
BVF PARTNERS L P/IL10% Owner05/21/202013,701,588
Wong StephanieSR. VP, FINANCE & SECRETARY04/15/202040,000
Orford KeithChief Medical Officer02/20/202024,168
Orford KeithChief Medical Officer12/23/201918,126
BVF PARTNERS L P/IL10% Owner11/20/2019750,847
BVF PARTNERS L P/IL10% Owner11/14/2019433,005
BVF PARTNERS L P/IL10% Owner10/30/20192,153,272
BVF PARTNERS L P/IL10% Owner10/29/20194,157,340
Molineaux ChristopherSR. VP, DEVELOPMENT06/25/2019200,208
Molineaux SusanPRESIDENT AND CEO06/25/2019200,208
Sjogren EricSR. VP, DRUG DISCOVERY06/24/201920,869
Wong StephanieSR. VP, FINANCE & SECRETARY06/19/201926,400
Parlati FrancescoVP, RESEARCH06/17/201916,489
Orford KeithChief Medical Officer06/17/20192,502
Orford KeithChief Medical Officer05/22/20192,496
Orford KeithChief Medical Officer04/15/20192,633
Orford KeithChief Medical Officer03/15/20192,681
Orford KeithChief Medical Officer03/11/20199,390
Orford KeithSR. VP, CLINICAL DEVELOPMENT10/15/20181,894
Orford KeithSR. VP, CLINICAL DEVELOPMENT10/11/20187,512
Sjogren EricSR. VP, DRUG DISCOVERY04/03/20188,069
Molineaux SusanPRESIDENT AND CEO03/02/201871,259
Parlati FrancescoVP, RESEARCH02/20/20184,891
Molineaux ChristopherSR. VP, DEVELOPMENT03/02/201817,947
Wong StephanieSR VP, FINANCE AND SECRETARY02/23/201826,400
Parlati FrancescoVP, RESEARCH02/20/20184,891
Molineaux SusanPRESIDENT AND CEO12/05/201721,257
Molineaux ChristopherSR. VP, DEVELOPMENT12/05/201713,370
ADAGE CAPITAL PARTNERS GP, L.L.C.10% Owner09/28/2017589,000
ADAGE CAPITAL PARTNERS GP, L.L.C.10% Owner09/27/20172,899,740
ADAGE CAPITAL PARTNERS GP, L.L.C.10% Owner09/26/20175,519,360
Wong StephanieVP, FINANCE AND SECRETARY07/17/201765,385
Orford KeithSR. VP, CLINICAL DEVELOPMENT07/17/201738,823
Hecht CurtisSVP, BUS. & CORP. DEVELOPMENT07/06/201712,600
Hecht CurtisSVP, BUS. & CORP. DEVELOPMENT05/19/201710,400
ADAGE CAPITAL PARTNERS GP, L.L.C.10% Owner03/22/20174,999,991
Hecht CurtisSVP, BUS. & CORP. DEVELOPMENT03/13/20178,400
Hecht CurtisSee Remarks03/02/20176,600
Molineaux SusanPRESIDENT AND CEO12/19/201647,309
Molineaux ChristopherSR. VP, DEVELOPMENT12/19/201617,739
ADAGE CAPITAL PARTNERS GP, L.L.C.10% Owner11/16/20161,575,000
Molineaux SusanPRESIDENT AND CEO07/20/201653,218
Molineaux ChristopherSR. VP, DEVELOPMENT07/20/201619,820
Bennett Mark KSR. VP, RESEARCH12/29/201516,617
Molineaux SusanPRESIDENT AND CEO12/21/201541,525
Molineaux ChristopherSR. VP, DEVELOPMENT12/21/201517,739
Hecht CurtisVP, BUS. & CORP. DEVELOPMENT11/16/20156,385
ADAGE CAPITAL PARTNERS GP LLC10% Owner09/23/2015243,768
ADAGE CAPITAL PARTNERS GP LLC10% Owner09/22/2015400,880
ADAGE CAPITAL PARTNERS GP LLC10% Owner09/04/201513,685
ADAGE CAPITAL PARTNERS GP LLC10% Owner09/03/2015521,840
ADAGE CAPITAL PARTNERS GP LLC10% Owner08/26/2015150,010
ADAGE CAPITAL PARTNERS GP LLC10% Owner08/28/2015237,645
ADAGE CAPITAL PARTNERS GP LLC10% Owner08/27/2015520,207
Hecht CurtisVP, BUS. & CORP. DEVELOPMENT08/20/20155,280
Waddill William D.SR. VP & CFO07/14/201534,650
Molineaux SusanPRESIDENT AND CEO07/13/2015109,890
Molineaux ChristopherSR. VP, DEVELOPMENT07/13/201540,684
Bennett Mark KSR. VP, RESEARCH07/08/201528,174
Waddill William D.SENIOR VP & CFO12/16/201423,284
ADAGE CAPITAL PARTNERS GP LLC10% Owner10/15/2014264,250
ADAGE CAPITAL PARTNERS GP LLC10% Owner10/14/2014384,750
ADAGE CAPITAL PARTNERS GP LLC10% Owner10/13/2014615,578
Delphi Management Partners VIII, L.L.C.10% Owner10/07/201448,350
Delphi Management Partners VIII, L.L.C.10% Owner10/07/20144,951,650
PAKIANATHAN DEEPIKADirector10/07/201448,350
PAKIANATHAN DEEPIKADirector10/07/20144,951,650
Advanced Technology Ventures VIII LP10% Owner10/07/20143,000,000
MORGENTHALER VENTURE PARTNERS IX LP10% Owner10/07/201418,119,150
MORGENTHALER VENTURE PARTNERS IX LP10% Owner10/07/20143,500,000
Christoffersen Ralph EDirector10/07/20143,500,000
George JeanDirector10/07/20143,000,000
ADAGE CAPITAL PARTNERS GP LLC10% Owner10/01/20148,000,000
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR CALITHERA BIOSCIENCES INC
LOADING...